<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-891" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neuroanatomy, Pupillary Dilation Pathway</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lykstad</surname>
            <given-names>Jacqueline</given-names>
          </name>
          <aff>Midwestern University - AZCOM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Reddy</surname>
            <given-names>Vamsi</given-names>
          </name>
          <aff>McKinsey &#x00026; Company</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hanna</surname>
            <given-names>Andrew</given-names>
          </name>
          <aff>UCLA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jacqueline Lykstad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vamsi Reddy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andrew Hanna declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-891.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The pupillary dilation pathway is a sympathetically driven response beginning in the hypothalamus and ending with the contraction of the dilator pupillae muscle. It is for this reason&#x000a0;that pupillary dilation may result from any physical or emotional stress that triggers the autonomic sympathetic nervous system, which is&#x000a0;mediated&#x000a0;by the&#x000a0;hypothalamus.</p>
        <p>The pupillary dilation pathway is a three-neuron pathway; disruptions anywhere along the oculosympathetic pathway may cause Horner syndrome, which is a classic triad of ptosis, miosis, and anhydrosis of the face due to loss of sympathetic innervation. It is essential to avoid damaging the superior cervical ganglion during cervical surgery, as such damage could prompt the development of Horner syndrome.</p>
        <p>Although Horner syndrome is predominantly a clinical diagnosis, in more subtle cases, administration of topical cocaine to the eye for confirmation secondary to cocaine's sympathetically activating qualities is an option. One of cocaine's mechanisms of action is to block the reuptake of norepinephrine at the neuromuscular junction. Topical cocaine in a person without Horner's syndrome will cause pupillary dilatation. Topical cocaine in a person with Horner syndrome will lead to minimal or no dilation at all. &#x000a0;In addition to Horner syndrome, chronic opiate abuse can cause miosis.</p>
      </sec>
      <sec id="article-891.s2" sec-type="Structure and Function">
        <title>Structure and Function</title>
        <p>The pupillary dilation pathway is a sympathetically driven response to stimuli and is a three-neuron pathway.<xref ref-type="bibr" rid="article-891.r1">[1]</xref> The first-order neuron begins in the hypothalamus and descends through the midbrain to synapse onto the spinal cords ciliospinal center of Budge, found between C8 to T2. The second-order neuron, the preganglionic sympathetic neuron, exits the spinal cord through the ventral roots and ascends through the thorax, near the lung apex and subclavian vessels, onto the superior cervical ganglion.</p>
        <p>The superior cervical ganglion appears opposite the second and third cervical vertebrae,&#x000a0;near the angle of the mandible and the bifurcation of the common carotid artery.<xref ref-type="bibr" rid="article-891.r2">[2]</xref> The third-order postganglionic neurons travel along the periarterial carotid plexus through the cavernous sinus. These axons then enter the orbit upon the short and long ciliary nerves (branches of V1, the ophthalmic division of CN V - the trigeminal nerve) to synapse on the dilator pupillae muscle, causing pupillary dilation.</p>
      </sec>
      <sec id="article-891.s3" sec-type="Blood Supply and Lymphatics">
        <title>Blood Supply and Lymphatics</title>
        <p>Blood supply to the sympathetic chain and ganglia is primarily via the ascending pharyngeal artery, ascending cervical artery, thyrocervical trunk, and supreme intercostal arteries.<xref ref-type="bibr" rid="article-891.r3">[3]</xref> The internal jugular vein supplies the venous drainage to this region. As the pathway ascends past the superior cervical ganglion, the blood supply is from the internal carotid artery, followed by the ophthalmic artery. Additionally, as the pathway ascends, lymphatic drainage follows regional lymph nodes.</p>
      </sec>
      <sec id="article-891.s4" sec-type="Surgical Considerations">
        <title>Surgical Considerations</title>
        <p>Any disruption along the three neuron pathways can result in loss of pupillary dilation. Although rare, damage to the superior cervical ganglion can occur as a complication of anterior or posterior cervical spine surgery, or surgery involving the thoracic outlet or lung apex. This damage presents as an abnormally small pupil with the inability to dilate due to the disruption of the cervical sympathetic nerves, known as Horner&#x02019;s syndrome.<xref ref-type="bibr" rid="article-891.r1">[1]</xref>&#x000a0;Horner syndrome is a classic triad of ipsilateral ptosis, miosis, and anhydrosis of the face due to the disruption of the sympathetic pathway in the head and neck.</p>
        <p>Although the diagnosis of Horner syndrome is predominantly clinical, in subtle cases, confirmation is possible by applying topical cocaine eye drops.<xref ref-type="bibr" rid="article-891.r4">[4]</xref> Cocaine is a stimulant that activates the sympathetic nervous system and acts by blocking the reuptake of norepinephrine, dopamine, and serotonin at the synaptic cleft. Since pupillary dilation is a sympathetic function, a classic sign of cocaine and other stimulant use is dilated pupils. If there is a disruption of the pupillary dilation pathway, in this case, via damage to the superior cervical ganglion, applying cocaine eye drops to the ipsilateral eye will not produce pupillary dilation. Therefore, in the presence of the triad mentioned above, if there is no pupillary dilation with the administration of cocaine eye drops, Horner&#x02019;s syndrome can be confirmed.</p>
        <p>Of note, apraclonidine&#x000a0;eye drops are also an option in the place of cocaine eye drops.<xref ref-type="bibr" rid="article-891.r5">[5]</xref> Horner syndrome can also occur secondary to a variety of causes, located anywhere along the pupillary dilation pathway. These include dissection of the carotid artery,<xref ref-type="bibr" rid="article-891.r6">[6]</xref> brachial plexus injury, neck mass, cervicothoracic spinal lesion, and Pancoast tumors, among many others.</p>
      </sec>
      <sec id="article-891.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Clinically, monitoring pupil dilation is intrinsic to the management of opioid overdose. According to the CDC&#x02019;s 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes, although opioid prescribing has continued to decrease through 2017, drug overdose deaths in the United States reached a record high in 2016 of 63,632.<xref ref-type="bibr" rid="article-891.r7">[7]</xref>&#x000a0;Of these fatalities, 66.4% involved opioids (42,249), the most common of which were synthetic opioids other than methadone (19,413), prescription opioids (17,087), and heroin (15,469). Amidst the opioid crisis, it is imperative to understand the treatment of opioid overdose.&#x000a0;</p>
        <p>Opioids are parasympathomimetics that act predominantly on mu receptors to produce feelings of euphoria, analgesia, and sedation. In toxic doses, opioids cause depressed mental status, respiratory depression (&#x0003c;12/min), decreased tidal volume, and pupillary constriction, or miosis. Due to respiratory depression, initial management should focus on airway and breathing, with preparation to mechanically ventilate if it becomes necessary. These measures are closely followed by the administration of naloxone, ideally via the intravenous route, which is a short-acting pure opioid antagonist.</p>
        <p>Naloxone has a duration of approximately two hours, and repeat administration may be necessary if respiratory depression and coma return, especially if the patient ingested a long-acting opioid. Since naloxone reverses pupillary constriction, administration via injection can continue until pupillary dilation takes place. Similarly, the clinical team can monitor the size of the patient&#x02019;s pupils to assess whether a subsequent dose is necessary, although monitoring&#x000a0;of pupils should take place in conjunction&#x000a0;with observation for the return of respiratory depression. Of note, naloxone is available OTC in many states, and expanded access to naloxone is&#x000a0;essential for reducing opioid overdose morbidity and mortality.<xref ref-type="bibr" rid="article-891.r8">[8]</xref></p>
        <p>Another common clinical scenario associated with pupillary dilation is an uncal brain herniation, a complication of&#x000a0;high intracranial pressure in which a portion of the temporal lobe herniates over the tentorium and places pressure on the midbrain. However, the associated pupillary dilation is not from the activation of the pupillary dilation pathway. Instead, it is from compression of the oculomotor nerve, which causes altered parasympathetic input to the ipsilateral eye.<xref ref-type="bibr" rid="article-891.r9">[9]</xref> Since pupillary constriction occurs parasympathetically, parasympathetic paralysis results in loss of pupillary constriction and hence, pupillary dilation.</p>
        <p>Additionally, pupillary dilation as an adaptation to low levels of light is due to the pupillary light reflex, in which varying intensities of light fall on the retinal ganglion cells and cause pupillary constriction or dilation; this is a separate pathway from the pupillary dilation pathway.&#x000a0;</p>
      </sec>
      <sec id="article-891.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=891&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=891">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/891/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=891">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-891.s7">
        <fig id="article-891.image.f1" position="float" orientation="portrait">
          <caption>
            <p>The left optic nerve and the optic tracts. A Marcus Gunn pupil indicates an afferent defect, usually at the level of the retina or optic nerve. Moving a bright light from the unaffected eye to the affected eye would cause both eyes to dilate, because the ability to perceive the bright light is diminished. Contributed by Wikimedia Commons, Henry Vandyke Carter - Henry Gray (1918) (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Gray773" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-891.s8">
        <title>References</title>
        <ref id="article-891.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Khan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Bollu</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <chapter-title>Horner Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>10</day>
            <pub-id pub-id-type="pmid">29763176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-891.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitsuoka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kikutani</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Morphological relationship between the superior cervical ganglion and cervical nerves in Japanese cadaver donors.</article-title>
            <source>Brain Behav</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>e00619</fpage>
            <pub-id pub-id-type="pmid">28239529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-891.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tubbs</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Salter</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wellons</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Oakes</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Blood supply of the human cervical sympathetic chain and ganglia.</article-title>
            <source>Eur J Morphol</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>283</fpage>
            <page-range>283-8</page-range>
            <pub-id pub-id-type="pmid">15101443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-891.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Aymard</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Denier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seghir</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abitbol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boddaert</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bremond-Gignac</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Robert</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of cocaine drops in investigating infant anisocoria.</article-title>
            <source>Eur J Paediatr Neurol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>852</fpage>
            <page-range>852-857</page-range>
            <pub-id pub-id-type="pmid">28807373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-891.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper-Knock</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pepper</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hodgson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sharrack</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Early diagnosis of Horner syndrome using topical apraclonidine.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>214</fpage>
            <page-range>214-6</page-range>
            <pub-id pub-id-type="pmid">21566530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-891.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garberi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ravizza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Borromeo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rossetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cisini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Motta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Birkhoff</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Unusual case of traumatic carotid artery dissection occurred during a work-related activity. A case report.</article-title>
            <source>Med Lav</source>
            <year>2018</year>
            <month>Oct</month>
            <day>30</day>
            <volume>110</volume>
            <issue>5</issue>
            <fpage>387</fpage>
            <page-range>387-390</page-range>
            <pub-id pub-id-type="pmid">30378589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-891.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moberg</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The role of managed care professionals and pharmacists in combating opioid abuse.</article-title>
            <source>Am J Manag Care</source>
            <year>2018</year>
            <month>May</month>
            <volume>24</volume>
            <issue>10 Suppl</issue>
            <fpage>S215</fpage>
            <page-range>S215-S223</page-range>
            <pub-id pub-id-type="pmid">29851451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-891.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eggleston</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Podolak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Pacelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Keenan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wojcik</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A randomized usability assessment of simulated naloxone administration by community members.</article-title>
            <source>Addiction</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>113</volume>
            <issue>12</issue>
            <fpage>2300</fpage>
            <page-range>2300-2304</page-range>
            <pub-id pub-id-type="pmid">30107641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-891.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ritter</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Muizelaar</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fatouros</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bullock</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Brain stem blood flow, pupillary response, and outcome in patients with severe head injuries.</article-title>
            <source>Neurosurgery</source>
            <year>1999</year>
            <month>May</month>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>941</fpage>
            <page-range>941-8</page-range>
            <pub-id pub-id-type="pmid">10232526</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
